Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Don't Ask Rambi -- Ignore unavailable to you. Want to Upgrade?

To: Ilaine who wrote (37328)	9/7/1999 2:53:00 AM
From: Krowbar	Read Replies (1) \| Respond to of 71178

There is recent evidence that the birth defects that resulted from taking thalidomide may not have been due to the drugs toxicity, but from it's intended effect of causing the woman not to vomit. It seems that there are critical times, when growing fetal cells are differentiating, they are very susceptible to damage from some of the products of digestion. What they are is yet unknown, but it may very well be that the vomiting of a woman is an important part of the pregnancy. Other than fetuses, there have only been minor side effects observed in patients taking the drug for leprosy, some as long as 10 years. It is being studied for use in auto-immune diseases. Del